These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 29180619

  • 21. Ubiquitin-SUMO circuitry controls activated fanconi anemia ID complex dosage in response to DNA damage.
    Gibbs-Seymour I, Oka Y, Rajendra E, Weinert BT, Passmore LA, Patel KJ, Olsen JV, Choudhary C, Bekker-Jensen S, Mailand N.
    Mol Cell; 2015 Jan 08; 57(1):150-64. PubMed ID: 25557546
    [Abstract] [Full Text] [Related]

  • 22. Cystic fibrosis transmembrane conductance regulator degradation: cross-talk between the ubiquitylation and SUMOylation pathways.
    Ahner A, Gong X, Frizzell RA.
    FEBS J; 2013 Sep 08; 280(18):4430-8. PubMed ID: 23809253
    [Abstract] [Full Text] [Related]

  • 23. The Epstein-Barr virus miR-BHRF1-1 targets RNF4 during productive infection to promote the accumulation of SUMO conjugates and the release of infectious virus.
    Li J, Callegari S, Masucci MG.
    PLoS Pathog; 2017 Apr 08; 13(4):e1006338. PubMed ID: 28414785
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
    Yang WS, Campbell M, Kung HJ, Chang PC.
    J Vis Exp; 2018 Jan 29; (131):. PubMed ID: 29443041
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. SUMO-Targeted Ubiquitin Ligases and Their Functions in Maintaining Genome Stability.
    Chang YC, Oram MK, Bielinsky AK.
    Int J Mol Sci; 2021 May 20; 22(10):. PubMed ID: 34065507
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Small heat shock proteins target mutant cystic fibrosis transmembrane conductance regulator for degradation via a small ubiquitin-like modifier-dependent pathway.
    Ahner A, Gong X, Schmidt BZ, Peters KW, Rabeh WM, Thibodeau PH, Lukacs GL, Frizzell RA.
    Mol Biol Cell; 2013 Jan 20; 24(2):74-84. PubMed ID: 23155000
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The Sumo-targeted ubiquitin ligase RNF4 regulates the localization and function of the HTLV-1 oncoprotein Tax.
    Fryrear KA, Guo X, Kerscher O, Semmes OJ.
    Blood; 2012 Feb 02; 119(5):1173-81. PubMed ID: 22106342
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation.
    Erker Y, Neyret-Kahn H, Seeler JS, Dejean A, Atfi A, Levy L.
    Mol Cell Biol; 2013 Jun 02; 33(11):2163-77. PubMed ID: 23530056
    [Abstract] [Full Text] [Related]

  • 35. Conserved function of RNF4 family proteins in eukaryotes: targeting a ubiquitin ligase to SUMOylated proteins.
    Sun H, Leverson JD, Hunter T.
    EMBO J; 2007 Sep 19; 26(18):4102-12. PubMed ID: 17762864
    [Abstract] [Full Text] [Related]

  • 36. Concerted action of the ubiquitin-fusion degradation protein 1 (Ufd1) and Sumo-targeted ubiquitin ligases (STUbLs) in the DNA-damage response.
    Køhler JB, Jørgensen ML, Beinoraité G, Thorsen M, Thon G.
    PLoS One; 2013 Sep 19; 8(11):e80442. PubMed ID: 24265825
    [Abstract] [Full Text] [Related]

  • 37. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
    Zhang J, Goodson ML, Hong Y, Sarge KD.
    J Biol Chem; 2008 Mar 21; 283(12):7464-9. PubMed ID: 18211895
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.